Displaying 21 - 30 of 912 results
-
Patient experience survey timetablesTimetables outlining the survey periods for the patient experience surveys.
-
Te Tāhū Hauora Health Quality & Safety Commission policy for consumer and whānau engagement, fees and reimbursementPolicy for paying consumers who are involved with Health Quality & Safety Commission work.
-
Vital sign charts and early warning systems: A scoping literature reviewAdapt Research, on behalf of Te Tāhū Hauora Health Quality & Safety Commission has undertaken a scoping review of recent literature in 2024 to ensure the national adult and maternity vital signs charts remain aligned to best practice.
-
Communications toolkit for the home and community support services experience surveyThis toolkit is a guide on promoting the 2024 home and community support services experience survey to raise awareness and encourage people to take part.
-
Specify brand advice guidance – updated July 2023Refreshed guidelines for the application of specify brand advice (SBA) for medicines within electronic systems.
-
Patient experience surveys: flyer/poster for patientsThese documents can be used as a flyer or poster for patients to promote the patient experience survey in hospitals, PHOs and general practices. They are available in a range of languages.
-
Aotearoa New Zealand Tall Man lettering list (October 2023)The Aotearoa New Zealand Tall Man lettering list (updated October 2023) includes look-alike, sound-alike medicine names that have been predicted to pose the greatest risk to patient safety.
-
Statement of Performance Expectations | Ngā Paearu Mahi 2024/25The Statement of Performance Expectations for Te Tāhū Hauora Health Quality & Safety Commission for the period 1 July 2024 to 30 June 2025.
-
Rehabilitation collaborative review: 1 year on | He arotakenga haumanu ngātahi: 1 tau neiA review of the rehabilitation collaborative, 1 year on.
-
Thematic analysis of maternity adverse events reported 1 July 2018–30 June 2023This report is an analysis of maternity-specific data from a 5-year period (1 July 2018–30 June 2023).